Company Filing History:
Years Active: 2022
Title: Eric Krauland: Innovator in Antibody Development
Introduction
Eric Krauland is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for medical treatments and diagnostics.
Latest Patents
Eric Krauland holds a patent for an "Anti-PCSK9 antibody and use thereof." This invention provides an antibody that specifically binds to proprotein convertase subtilisin/kexin type 9 (PCSK9). The patent also includes an antigen-binding fragment of the antibody, a composition comprising the antibody or the fragment, and a nucleic acid that encodes the antibody or the fragment. Additionally, it describes a host cell containing the nucleic acid and applications of the antibody and fragment in treatment and diagnosis.
Career Highlights
Eric Krauland is currently employed at Innovent Biologics (Suzhou) Co., Ltd. His role at the company allows him to work on cutting-edge research and development in the field of biologics. His expertise in antibody technology has positioned him as a key player in the industry.
Collaborations
Eric collaborates with talented professionals in his field, including Andy Tsun and Jonathan P Belk. These collaborations enhance the innovative capacity of his projects and contribute to the advancement of therapeutic solutions.
Conclusion
Eric Krauland's work in antibody development exemplifies the impact of innovation in biotechnology. His contributions are paving the way for new treatments and diagnostic methods that can significantly improve patient care.